Citation Impact
Citing Papers
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
2017 Standout
β-Amyloid accumulation in the human brain after one night of sleep deprivation
2018
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Magnetite-Amyloid-β deteriorates activity and functional organization in an in vitro model for Alzheimer’s disease
2015
Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease –conformist, nonconformist, and realistic prospects for AD pathogenesis
2018
Amyloid‐ß‐directed immunotherapy for Alzheimer's disease
2014
Engineering precision nanoparticles for drug delivery
2020 Standout
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
2020 Standout
Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model
2019
Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate
2016
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
The glymphatic pathway in neurological disorders
2018 Standout
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Inhibition of Amyloid Formation
2012
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
2018
Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody
2016
A highly insoluble state of Aβ similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice
2008
Astrocyte Biomarkers in Alzheimer’s Disease
2019
Amyloid‐beta oligomerization in Alzheimer dementia versus high‐pathology controls
2012
Prion-like aggregates: infectious agents in human disease
2010
Alzheimer's disease
2016 Standout
Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy
2019
The Amyloid State of Proteins in Human Diseases
2012 Standout
Aggregation and fibril morphology of the Arctic mutation of Alzheimer’s Aβ peptide by CD, TEM, STEM and in situ AFM
2012
Design of amyloidogenic peptide traps
2024 StandoutNobel
Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease
2013
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
2012 Standout
Down syndrome
2020 Standout
The amyloid state and its association with protein misfolding diseases
2014 Standout
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
The amyloid hypothesis of Alzheimer's disease at 25 years
2016 Standout
FeIII‐Doped Two‐Dimensional C3N4 Nanofusiform: A New O2‐Evolving and Mitochondria‐Targeting Photodynamic Agent for MRI and Enhanced Antitumor Therapy
2016
Alzheimer's disease
2017 Standout
Light and heat control over secondary structure and amyloid-like fiber formation in an overcrowded-alkene-modified Trp zipper
2015 StandoutNobel
Lecanemab in Early Alzheimer’s Disease
2022 Standout
Amyloid β peptide cleavage by kallikrein 7 attenuates fibril growth and rescues neurons from Aβ-mediated toxicity in vitro
2013 StandoutNobel
New ELISAs with high specificity for soluble oligomers of amyloid β‐protein detect natural Aβ oligomers in human brain but not CSF
2013
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
P4‐316: Stabilization of neurotoxic Alzheimer amyloid‐beta oligomers by protein engineering
2011
Clinical translation of immunoliposomes for cancer therapy: recent perspectives
2018
A monoclonal antibody against synthetic Aβ dimer assemblies neutralizes brain‐derived synaptic plasticity‐disrupting Aβ
2011
Stabilization of neurotoxic Alzheimer amyloid-β oligomers by protein engineering
2010
Water-Soluble Conjugated Polymers for Imaging, Diagnosis, and Therapy
2012 Standout
Magnetite pollution nanoparticles in the human brain
2016 Standout
Works of Dag Sehlin being referenced
Sensitive detection of Aβ protofibrils by proximity ligation - relevance for Alzheimer's disease
2010
Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer’s Disease
2018
Cationization increases brain distribution of an amyloid-beta protofibril selective F(ab’)2 fragment
2017
Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer’s disease
2016
Large Aggregates Are the Major Soluble Aβ Species in AD Brain Fractionated with Density Gradient Ultracentrifugation
2012
Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons
2016
Sensitive ELISA detection of amyloid‐β protofibrils in biological samples
2007
Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
2016
An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease
2009
Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease
2014
Heavy-Chain Complementarity-Determining Regions Determine Conformation Selectivity of Anti-Aβ Antibodies
2010
Specific Uptake of an Amyloid-β Protofibril-Binding Antibody-Tracer in AβPP Transgenic Mouse Brain
2013
Interference from Heterophilic Antibodies in Amyloid-β Oligomer ELISAs
2010